Oscar Health Inc (OSCR) concluded trading on Wednesday at a closing price of $13.89, with 9.88 million shares of worth about $137.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.84% during that period and on Wednesday the price saw a loss of about -7.46%. Currently the company’s common shares owned by public are about 217.98M shares, out of which, 180.95M shares are available for trading.
Stock saw a price change of -15.66% in past 5 days and over the past one month there was a price change of 10.06%. Year-to-date (YTD), OSCR shares are showing a performance of 3.35% which decreased to -33.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.20 but also hit the highest price of $23.79 during that period. The average intraday trading volume for Oscar Health Inc shares is 6.00 million. The stock is currently trading -9.33% below its 20-day simple moving average (SMA20), while that difference is up 0.81% for SMA50 and it goes to -12.37% lower than SMA200.
Oscar Health Inc (NYSE: OSCR) currently have 217.98M outstanding shares and institutions hold larger chunk of about 61.79% of that.
The stock has a current market capitalization of $3.54B and its 3Y-monthly beta is at 1.77. PE ratio of stock for trailing 12 months is 49.86, while it has posted earnings per share of $0.28 in the same period. Its PEG reads 0.30 while making debt-to-equity ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OSCR, volatility over the week remained 5.63% while standing at 7.17% over the month. Stock’s fiscal year EPS is expected to rise by 631.83% while it is estimated to increase by 36.13% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on March 13, 2025 offering an Equal weight rating for the stock and assigned a target price range of between $20 and $16 to it. Coverage by Jefferies stated Oscar Health Inc (OSCR) stock as an Underperform in their note to investors on December 10, 2024, suggesting a price target of $12 for the stock. On November 06, 2024, BofA Securities Downgrade their recommendations, while on October 07, 2024, UBS Initiated their ratings for the stock with a price target of $23. Stock get an Overweight rating from Piper Sandler on June 26, 2024.
